About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Nashville | 10,809 Studies Near You

Clinical TrialsNashville

Clinical Trials in Nashville

Discover 10,809 clinical trials near Nashville, Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2021-2040 of 10,809 trials

CompletedA Study for Patients Who Completed VITALITY-ALS (CY 4031)The purpose of this study is to assess the long-term safety and tolerability of tirasemtiv in patients with ALS who had completed the double-blind placebo-controlled study of…NCT02936635·Phoenix, Arizona and 66 others

Find Trials by Condition in Nashville

Breast Cancerin Nashville Lung Cancerin Nashville Prostate Cancerin Nashville Colorectal Cancerin Nashville Melanomain Nashville Leukemiain Nashville Lymphomain Nashville Pancreatic Cancerin Nashville Ovarian Cancerin Nashville Brain Cancerin Nashville

Data from ClinicalTrials.govTerms

CompletedA Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's DiseaseThe purpose of this study is to evaluate the efficacy and safety of PF 04494700 in participants with mild to moderate Alzheimer's disease.NCT00566397·Phoenix, Arizona and 61 others

Active not recruitingIpilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by SurgeryThis randomized phase III trial studies ipilimumab to see how well it works compared to high-dose interferon alfa-2b in treating patients with high-risk stage III-IV melanoma that…NCT01274338·Birmingham, Alabama and 936 others

CompletedModel 4965 Post-Approval StudySafety and effectiveness will be summarized for the model 4965 lead. This study was conducted within Medtronic's System Longevity Study (SLS).NCT01076348·Birmingham, Alabama and 106 others

TerminatedAtezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast CancerThis phase I/II trial studies the side effects and best dose of idasanutlin when given together with atezolizumab, and to see how well atezolizumab and cobimetinib or idasanutlin…NCT03566485·Nashville, Tennessee

CompletedmLab App Plus: A Randomized Controlled Trial of a Mobile Health (mHealth) InterventionMen who have sex with men (MSM), especially young men who have sex with men (YMSM), and transgender women (TGW) have some of the highest rates of HIV and syphilis diagnoses in the…NCT06059443·New York, New York and 1 other

UnknownMonitoring and Adjustment of Medication Therapy for Patients With Heart DiseaseExisting trials for the patient with coronary heart disease evaluate the interdisciplinary team dynamic where pharmacists (pharmacotherapists) provide therapeutic recommendations…NCT01427218·Nashville, Tennessee

Active not recruitingSafety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCThis is a First-in-Human Phase IA/IB/II open label dose escalation study of intravenous (IV) administration of ONC-392, a humanized anti-CTLA4 IgG1 monoclonal antibody, as single…NCT04140526·Springdale, Arkansas and 36 others

CompletedSafety and Efficacy of NT 201 (IncobotulinumtoxinA [Xeomin]) in the Treatment of Glabellar Frown LinesThe study objective was to investigate the safety and efficacy of incobotulinumtoxinA (Xeomin) during repeat dose treatment of glabellar frown lines.NCT00512135·Los Angeles, California and 24 others

CompletedPhase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC)A Phase 2a, multicenter, randomized, double-blind, dose-ranging, placebo-controlled, study to evaluate the safety, tolerability, and PK of PLN-74809 in participants with primary…NCT04480840·Pasadena, California and 59 others

WithdrawnA Study of Panobinostat (LBH589) as Second-Line Therapy in Patients With Chronic Graft-Versus-Host DiseaseThere is a clear need for effective, steroid-sparing agents for the management of chronic graft-versus-host disease (GVHD).NCT01028313·Nashville, Tennessee

Active not recruitingMEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform NeurofibromasThis study evaluates mirdametinib (PD-0325901) in the treatment of symptomatic inoperable neurofibromatosis type-1 (NF1)-associated plexiform neurofibromas (PNs).NCT03962543·Birmingham, Alabama and 42 others

CompletedHigh Sensitivity cTnT Rules Out Cardiac Insufficiency Trial (TACIT)The purpose of this study is to better understand myocardial injury in AHF. Secondary analyses demonstrate the prognostic significance of troponin release.NCT02592135·Indianapolis, Indiana and 4 others

Active not recruitingDOMPE -MT Neurotrophic KeratitisTITLE: Toyos Clinic / A Phase 4 Study to Assess Longer Duration of Treatment with Cenegermin in Moderate to Severe Dry Eye-Associated Neurotrophic KeratitisNCT06947850·Nashville, Tennessee

CompletedA Study of the Safety and Efficacy of Tofimilast in Adult AsthmaticsThis is an initial proof of concept, phase to study to assess the safety and efficacy tofimilast for the chronic maintenance treatment of adults with persistent asthmaNCT00150397·Encinitas, California and 21 others

TerminatedMechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1The purpose of this study is to test the hypothesis that combined angiotensin receptor blockade (ARB)/neprilysin (NEP) inhibition potentiates the effects of exogenous bradykinin…NCT03738878·Nashville, Tennessee

RecruitingStudy With Phage for CF Subjects With Pseudomonas Lung InfectionThe goal of this Phase 2b clinical trial is to see if nebulized phage (BX004) can treat chronic Pseudomonas aeruginosa (PsA) lung infection in CF subjects.NCT06998043·Birmingham, Alabama and 13 others

TerminatedPhase 1/2 Study of the Safety and Efficacy of Rociletinib in Combination With Trametinib in Patients With mEGFR-positive Advanced or Metastatic Non-small Cell Lung CancerThe purpose of this study is to evaluate the safety and anti-tumor effect of rociletinib when administered in combination with trametinib.NCT02580708·St Louis, Missouri and 3 others

CompletedExploratory Study, Evaluating the Treatment Effect of Surgery Plus GLIADEL® Wafer in Patients With Metastatic Brain CancerThe purpose of this study is to determine the effect of the surgical intervention and insertion of GLIADEL wafers on the neurocognitive functioning in patients with metastatic…NCT00525590·Tucson, Arizona and 16 others

Active not recruitingAssessing Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction CancerThis is a Global Study of Neoadjuvant-Adjuvant Durvalumab or Placebo and FLOT Chemotherapy Followed by Adjuvant Durvalumab or Placebo in Patients with Resectable Gastric and…NCT04592913·Duarte, California and 155 others

PreviousPage 102 of 541Next

Diabetes

in Nashville

Heart Diseasein Nashville